EFFIX PHARMA AS
Operating
Å utvikle medisiner og kosttilskudd, samt delta som eier i selskaper
som driver med tilsvarende virksomhet.
Links
Organization
- Chairman of the board
- JK
- Years since formation
- 18 years
- since Apr 21, 2008
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Annual total result 2025
- -22,199
- NOK
- Total equity 2025
- -4,097,371
- NOK
Last update: May 27, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
JK | Chairman | 100 % indirectly |
JM | Alternate Member | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JK | Chairman | 100 % indirectly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 3,086,844Operating profit 2024: NOK 1,503,586Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -22,199 | -9,915 | -9,000 | -2,640 | -5,370 |
Total assets | 24,998 | 692 | 112 | 4,192 | 512 |
Total liabilities | 4,122,369 | 4,075,863 | 4,065,369 | 4,060,448 | 4,054,128 |
Total equity | -4,097,371 | -4,075,172 | -4,065,257 | -4,056,257 | -4,053,617 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 0 |
Total operating costs | 22,199 | 8,558 | 9,000 | 2,640 | 5,370 |
Operating result | -22,199 | -8,558 | -9,000 | -2,640 | -5,370 |
Financial income/costs | 0 | -1,357 | 0 | 0 | 0 |
Profit before tax | -22,199 | -9,915 | -9,000 | -2,640 | -5,370 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -22,199 | -9,915 | -9,000 | -2,640 | -5,370 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 0 |
Total current assets | 24,998 | 692 | 112 | 4,192 | 512 |
Total assets | 24,998 | 692 | 112 | 4,192 | 512 |
Short term debt | 692,359 | 645,854 | 635,359 | 630,439 | 626,119 |
Long term debt | 0 | 3,430,009 | 3,430,009 | 3,430,009 | 3,428,009 |
Total liabilities | 4,122,369 | 4,075,863 | 4,065,369 | 4,060,448 | 4,054,128 |
Contributed capital | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
Retained earnings | -4,197,371 | -4,175,172 | -4,165,257 | -4,156,257 | -4,153,617 |
Total equity | -4,097,371 | -4,075,172 | -4,065,257 | -4,056,257 | -4,053,617 |
Total equity and liabilities | 24,998 | 692 | 112 | 4,191 | 511 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises